From a drug development perspective, determining exactly how the various inhibitors bind to the Mps1 catalytic domain at the atom resolution level is important in order to to design better drugs to treat cancers of poor prognosis such as liver caner, which has shown great resilience to multiple types of drugs. The gene discussed is TTK; the disease is cancer.